Jane Street
RGC icon

Jane Street’s Regencell Bioscience RGC Stock Holding History

Jane Street’s Portfolio RGC Stock Details RGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.6K Buy
+12,900
New +$310K ﹤0.01% 10732
2025
Q4 		– Sell
-11,400
Closed -$176K – 12170
2025
Q3 		$176K Buy
+11,400
New +$164K ﹤0.01% 9769

Other funds holding RGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
FRM
Fox Run Management Greenwich, Connecticut $603M AUM 32% 1-Year Est. Return

Jane Street's RGC Position: Q2 2026 in Review

Jane Street opened a new position in Regencell Bioscience (RGC) in Q2 2026: 98,348 shares worth $599K. The stake represents ﹤0.01% of the portfolio and ranks #7606 among its holdings. This is a return to the name: Jane Street previously reported a position in RGC as recently as Q3 2025.

Jane Street first reported a position in RGC in Q3 2025 and has held it in 2 quarters since. 35 funds tracked by Wall St. Rank hold RGC as of Q2 2026.

  • Jane Street held 98,348 shares of Regencell Bioscience worth $599K as of Q2 2026.
  • Regencell Bioscience was a new Jane Street position in Q2 2026.
  • Regencell Bioscience made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7606 holding.
  • Jane Street first reported a position in Regencell Bioscience in Q3 2025 and has held it in 2 quarters since.
  • 35 funds tracked by Wall St. Rank held Regencell Bioscience as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.